总时间（秒）：26.68
问答时间（秒）：24.60

```json
{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "G",
          "position": "289"
        },
        "variant_string_id": "PARK2 C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin mutations are linked to autosomal recessive juvenile onset Parkinsonism. Parkin functions as a ubiquitin-protein ligase and has been implicated in the formation of Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the association between Parkin mutations and Parkinson's disease, establishing a clear disease mechanism related to Parkin function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the effect of the C289G mutation on Parkin's ability to induce mitophagy after treatment with mitochondrial uncoupler, which models dysfunctional mitochondria and the need for autophagy.",
          "judgment": "Yes",
          "reasoning": "The assay, focusing on mitophagy, directly assesses Parkin's ability to clear damaged mitochondria, which is central to the disease mechanism in Parkinson's."
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The text states that Parkin(C289G) fails to redistribute to damaged mitochondria and cannot induce mitophagy. However, it does not explicitly mention the use of wild-type Parkin as a positive control or a null mutant as a negative control within the provided text.",
          "judgment": "No",
          "reasoning": "The provided text does not detail the inclusion of standard positive and negative controls necessary to fulfill the requirements for basic controls."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Mitophagy assays are a commonly used method to assess Parkin function in neurodegenerative disease models, supported by widespread use in the field.",
          "judgment": "Yes",
          "reasoning": "Mitophagy assays are well-established within the field of neurodegenerative disease and thus validated through broader acceptance.",
          "next_step_or_outcome": "Proceed to Step 4"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The C289G mutation results in a failure of Parkin to induce mitophagy, demonstrating a loss of function relevant to Parkinson’s disease pathology. While the text does not detail comprehensive control experiments, the use of established assays and clear demonstration of loss of function support a PS3_supporting rating."
    }
  ]
}
```